Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTM2 | P28161 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.37 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.37 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.37 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.37 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.37 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
| ▸ | KAT2B | Q92831 | 7/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12966304 | 0.96 | GSTM2 (0.44) | GSTM2HRH3HDAC3HDAC4HDAC1 | |
| SCHEMBL13438510 | 0.91 | GSTM2 (0.39) | GSTM2HRH3HDAC3HDAC4HDAC1 | |
| SCHEMBL16310249 | 0.86 | GSTM2 (0.54) | GSTM2HRH3HDAC3HDAC4HDAC1 | |
| SCHEMBL17788964 | 0.82 | GSTM2 (0.47) | GSTM2HRH3HDAC3HDAC4HDAC1 | |
| SCHEMBL15507622 | 0.82 | GSTM2 (0.43) | GSTM2HRH3HDAC3HDAC4HDAC1 | |
| SCHEMBL12241928 | 0.81 | GSTM2 (0.44) | GSTM2HRH3HDAC3HDAC4HDAC1 | |
| SCHEMBL15507466 | 0.80 | HDAC3 (0.47) | GSTM2HRH3HDAC3HDAC4HDAC1 | |
| SCHEMBL15507618 | 0.80 | HDAC3 (0.47) | GSTM2HRH3HDAC3HDAC4HDAC1 | |
| SCHEMBL15507616 | 0.80 | HDAC3 (0.47) | GSTM2HRH3HDAC3HDAC4HDAC1 | |
| SCHEMBL15507465 | 0.80 | HDAC3 (0.47) | GSTM2HRH3HDAC3HDAC4HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110190291-A1 | Prodrug and Fluoregenic Compositions and Methods for Using the Same | REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION (US) | 2011-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190291-A1 | Prodrug and Fluoregenic Compositions and Methods for Using the Same | SLC19A1, SLC46A1, TFRC | GSTM2 752/4885HRH3 3274/4885HDAC3 2349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.